Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Respiratory Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05263895
What this trial is testing

Relative Bioavailability Study of 4 Different Formulations of PF-07321332 Relative to the Commercial Tablet Formulation

Who this might be right for
Bioavailability
Pfizer 12
Post-approval studies (Phase 4)UnknownNCT04429867
What this trial is testing

Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease

Who this might be right for
COVID-19
WellStar Health System 700
Not applicableStudy completedNCT05097677
What this trial is testing

Follow-up of Covid-19 Long Term Sequelae

Who this might be right for
COVID-19 PneumoniaCOVID-19 Respiratory InfectionCOVID-19 Acute Bronchitis+15 more
Azienda Ospedaliera Universitaria Integrata Verona 7,599
Large-scale testing (Phase 3)Ended earlyNCT04329195
What this trial is testing

ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 Pandemic

Who this might be right for
History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 Infection
Assistance Publique - Hôpitaux de Paris 44
Large-scale testing (Phase 3)WithdrawnNCT04848467
What this trial is testing

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older

Who this might be right for
SARS-CoV-2 InfectionCoronavirus Disease 2019 (COVID-19)
Bayer
Not applicableUnknownNCT04462367
What this trial is testing

Northeast COVID-19 and Pregnancy Study Group

Who this might be right for
COVID19Coronavirus InfectionPregnancy Disease+1 more
Instituto Materno Infantil Prof. Fernando Figueira 180
Not applicableStudy completedNCT04588363
What this trial is testing

COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Multisystem Inflammatory Syndrome in Children (MIS-C)Coronavirus Disease 2019 (COVID-19)
National Institute of Allergy and Infectious Diseases (NIAID) 244
Not applicableStudy completedNCT04327804
What this trial is testing

A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research

Who this might be right for
SARS-CoV Infection
UnitedHealth Group 139
Testing effectiveness (Phase 2)Looking for participantsNCT04652115
What this trial is testing

Defibrotide for the Treatment of Severe COVID-19

Who this might be right for
Covid19
Brigham and Women's Hospital 42
Testing effectiveness (Phase 2)Study completedNCT04533347
What this trial is testing

Tafenoquine in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID 19 Disease
60 Degrees Pharmaceuticals LLC 86
Large-scale testing (Phase 3)WithdrawnNCT04838847
What this trial is testing

Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19

Who this might be right for
CoronavirusCovid19SARS-CoV-2+1 more
CureVac
Testing effectiveness (Phase 2)UnknownNCT04338802
What this trial is testing

Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19

Who this might be right for
COVID-19NintedanibSafety+1 more
Huilan Zhang 96
Large-scale testing (Phase 3)UnknownNCT04780672
What this trial is testing

Clinical Study in the Treatment of Patients With COVID-19

Who this might be right for
COVID-19
Pharma VAM 330
Testing effectiveness (Phase 2)Study completedNCT04561219
What this trial is testing

Nitazoxanide Therapy for Patients With COVID-19 Pneumonia

Who this might be right for
Covid19Corona Virus InfectionPneumonia, Viral
Universidade Federal do Rio de Janeiro 500
Not applicableStudy completedNCT04602351
What this trial is testing

Communication in ICU During COVID-19

Who this might be right for
COVID-19Severe Acute Respiratory Syndrome Coronavirus 2Severe Acute Respiratory Syndrome
NMC Specialty Hospital 296
Very early researchWithdrawnNCT04323631
What this trial is testing

Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death

Who this might be right for
COVID-19
Rambam Health Care Campus
Not applicableStudy completedNCT07244731
What this trial is testing

The Prognostic Role of Red Blood Cell Distribution (RDW) in Severe COVID-19 Patients

Who this might be right for
COVID - 19PrognosisICU
Ankara University 146
Large-scale testing (Phase 3)Study completedNCT04960202
What this trial is testing

EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19

Who this might be right for
COVID-19
Pfizer 2,091
Post-approval studies (Phase 4)Active Not RecruitingNCT07086222
What this trial is testing

Efficacy and Safety of NVX-CoV2705

Who this might be right for
COVID-19Sars-CoV-2 Infection
Novavax 6,500
Not applicableStudy completedNCT04368845
What this trial is testing

Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study

Who this might be right for
COVID-19Comorbidities and Coexisting Conditions
University of Thessaly 82
Next Page